Latest Blogs

Jul 22, 2019
It was challenging to counsel a patient who responded to his cancer diagnosis by having affairs.
Jul 19, 2019
Dr. Zuhir Bodalal wanted to be able to offer chances to patients who would otherwise be out of options, so he needed to find a way to bridge different worlds.
Jul 11, 2019
Consensus among a multidisciplinary team may not be easy, but it is, ultimately, the goal. That, in and of itself, is the definition of quality care.
Jul 08, 2019
How does a group of talented, busy surgeons find the time to change their surgical paradigm? Dr. Nabil P. Rizk and I had an enlightening conversation about cost, value, quality of care, and process improvement.
Subscribe to this column

ASCO Commentary

ASCO Commentary provides an interactive platform for ASCO’s organizational leadership and senior staff to connect directly to ASCO’s membership and the wider oncology community.

Feb 21, 2018
Dr. Richard L. Schilsky describes ASCO's Targeted Agent and Profiling Utilization Registry (TAPUR) Study and similar independent studies worldwide.
Oct 28, 2016
Dr. Richard L. Schilsky outlines the Society's Target Agent and Profiling Utilization Registry (TAPUR) Study and similar international protocols. A global data sharing platform could greatly accelerate our ability to learn about new uses for currently approved targeted anticancer drugs.
Nov 02, 2015
Chief Medical Officer Dr. Richard L. Schilsky answers your questions about this exciting new opportunity in health care policy and advocacy.
Oct 26, 2015
Personalized cancer care is not a new concept, but its application has been enabled and enhanced by a far greater understanding of the biological underpinnings of cancer than ever existed before.
Nov 12, 2014
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. During the past six weeks I’ve had the opportunity to attend cancer meetings in four countries on three continents. In September, I represented ASCO at the annual meeting of the Chinese Society of Clinical Oncology (CSCO) in Xiamen,...
Feb 06, 2014
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. I’ve been a regular attendee of the Gastrointestinal Cancers Symposium since it began 11 years ago. This year’s meeting was among the very best with record attendance, superb educational talks and keynote lectures, multidisciplinary...